Intelsat, Cubic³ Complete Vehicle Satellite Connectivity Test, Advancing Ubiquitous Connectivity Vision
Groundbreaking Memorandum of Understanding brings seamless, global connectivity closer to reality for connected cars, agriculture, and heavy machinery vehicles
Intelsat and Cubic³ have successfully completed a critical vehicle satellite connectivity test, marking a significant milestone in their joint mission to create a seamless connectivity service for all types of vehicles. The test demonstrated successful integration between Intelsat satellites and Cubic³’s software platform, showcasing how terrestrial and non-terrestrial networks can seamlessly link to deliver always-on connectivity regardless of location.
“Our Memorandum of Understanding and successful test brings us closer to our vision of truly ubiquitous connectivity,” said Bruno Fromont, Intelsat Chief Technology Officer. “By combining Intelsat’s satellite expertise with Cubic³’s innovative connectivity platform, we’re creating solutions that will keep vehicles connected anywhere in the world, enabling critical functions from broadband connectivity, diagnostics to eventually supporting autonomous driving capabilities.”
The successful test focused on a commercial land mobile use case featuring Intelsat’s FlexMove Fleet product and Cubic³ Cloud interface, proving the viability of integrated connectivity solutions for heavy machinery customers. This demonstration represents a major step forward in the collaboration between Intelsat, Cubic³ and SoftBank Corp. The joint collaboration is expected to create a new, differentiated one-stop shop solution for the land mobile industry, offering customers the ability to create customized connectivity solutions that leverage both terrestrial cellular networks and non-terrestrial networks.
The collaboration addresses a critical gap in today’s increasingly connected world. Despite advances in autonomous mobility for connected cars, ships, drones, and other vehicles, many areas remain without ground-based mobile network coverage, requiring separate devices and accounts to connect to non-terrestrial networks. The Intelsat- Cubic³-SoftBank Corp. cooperative effort aims to eliminate this fragmentation, offering one device and one account that maintains connectivity across available networks worldwide.
Nick Power, Chief Technology Officer at Cubic³, highlighted the strategic importance of the collaboration: “Our work with Intelsat is foundational to delivering on the promise of software-defined vehicles. Car manufacturers need global, high-speed, always-on connectivity to transform into software-first entities and meet evolving consumer mobility demands. This test demonstrates how our technologies can work together to enable that future.”
The planned integrated solution will initially use geostationary (GEO) satellites for applications such as fleet management, telematics, predictive maintenance, and software updates in areas beyond terrestrial coverage. As new low Earth orbit (LEO) constellations launch, the system will evolve to support higher-bandwidth use cases including high-definition map downloads, and cloud-based vehicle diagnostics using digital twins. “Non-terrestrial networks are not just a backup option—they’re an essential component of the connectivity ecosystem that will power tomorrow’s vehicles,” Fromont said.
This collaboration also builds on the groundbreaking collaboration agreement signed in 2024 between SoftBank Corp. and Intelsat to create a single “Ubiquitous Network.” This network leverages the same standard architectures, interfaces, and processes that enable roaming between terrestrial cellular networks today, accelerating the commercial adoption of mobility solutions based on new 3GPP 5G standards for non-terrestrial networks.
About Intelsat
Intelsat’s global team of professionals is focused on providing seamless and secure, satellite-based communications to government, NGO and commercial customers through the company’s next-generation worldwide network and managed services. Bridging the digital divide by operating one of the world’s largest and most advanced satellite fleet and connectivity infrastructures, Intelsat enables people and their tools to speak over oceans, see across continents and listen through the skies to communicate, cooperate and coexist. Since its founding six decades ago, the company has been synonymous with satellite-industry “firsts” in service to its customers and the planet. Leaning on a legacy of innovation and focusing on addressing a new generation of challenges Intelsat team members now have their sights on the “next firsts” in space as they disrupt the field and lead in the digital transformation of the industry.
About Cubic³
Cubic³ provides advanced connectivity solutions for software-defined vehicles (SDVs) across 200+ countries. We help automotive, agriculture and transportation OEMs navigate the complexities of connecting vehicles while ensuring compliance with global regulations. With access to over 550 mobile networks, our smart connectivity empowers OEMs to innovate, scale and unlock new opportunities, driving efficiency and growth. In 2024, SoftBank Corp. and Cubic³ formed a strategic global partnership to pioneer the future of software-defined vehicles (SDVs) and other high-value Internet-of-Things (IoT) assets.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250514411770/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ecolab Life Sciences Opens New State-of-the-Art Bioprocessing Applications Laboratory in Pennsylvania, US14.5.2025 12:00:00 CEST | Press release
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecules, providing comprehensive technical support to biopharmaceutical companies and contract manufacturers operating from small-scale to full commercial production. This new development location is well positioned in the Eastern U.S., close to many large pharmaceutical operations and a hub of bioprocessing innovation. The lab is equipped with high-throughput process development tools and manufacturing scale chromatography columns, enabling biotech firms to receive turnkey support for process development. Large biopharma companies can utilize the applications lab throughout the entire development cycle, from early to late stage and commercialization; including characterizing alternative resins to help reduce manufacturin
10-Year Partnership Between ISN® and Yara International Enhances Ongoing Commitment to Contractor Safety14.5.2025 10:00:00 CEST | Press release
The global leader in crop nutrition continues to leverage ISNetworld® solutions to advance contractor compliance and safety practices ISN, the global leader in contractor and supplier information management services, celebrates 10 years of partnership with the European division of Yara International (Yara), a leading provider of crop nutrition and sustainable agricultural solutions. After a successful implementation in the Americas, Yara adopted ISNetworld across its European sites in 2015, expanding its use of the contractor management platform, streamlining processes, and improving operational efficiency. “Over the past decade, ISN has been instrumental to Yara’s contractor management processes in Norway and the Netherlands," said Steinar Bjelland, Procurement Manager at Yara. "Leveraging ISNetworld tools and services such as RAVS 360™ and acknowledgment form tracking, along with ISN’s multilingual support, has helped Yara optimise compliance, improve communication, and effectively a
Ares Management Opens Milan Office14.5.2025 10:00:00 CEST | Press release
Ares Management Corporation (NYSE: ARES) (“Ares”), a leading global alternative investment manager, announced today the opening of a new office in Milan, the firm’s latest office in Europe. The office will enhance Ares’ access to the Italian market, and its ability to raise and invest capital across its strategies, particularly within its European Direct Lending business, as well as the Wealth Management and European Real Estate platforms. This latest opening underscores Ares’ commitment to a highly localized approach to investing in Europe, which the firm entered in 2007 through the opening of a London office, followed by Paris, Frankfurt and Stockholm in 2009 and, most recently, Amsterdam and Madrid in 2019. Across its investment strategies, including European Direct Lending and European Real Estate, Ares has deployed over €1.6 billion to support Italian businesses and assets, as of March 31, 2025, and Ares expects to accelerate this activity in the coming years. Tyrone Cooney, Partn
Norli Liv & Pension Modernizes Investment Operations with Clearwater Analytics14.5.2025 09:00:00 CEST | Press release
Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, today announced that Danish pension provider, Norli Liv & Pension, part of the Norli group, has partnered with Clearwater to modernize its investment accounting, reporting and compliance operations. Clearwater will provide Norli with a single, consolidated view of all in-house and outsourced chief investment officer (OCIO) managed holdings across its public and private asset classes—enhancing investment transparency and empowering better, faster decision-making. The platform will also support regulatory compliance through automated workflows and robust, audit-ready reporting. By moving to Clearwater’s single instance, multi-tenant platform, Norli Liv & Pension will eliminate multiple legacy platforms, reduce manual work and accelerate its monthly close. The platform’s “single pane of glass” view will provide users across departments with unified access to accurate, timely data and a
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)14.5.2025 08:14:00 CEST | Press release
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show potential of efimosfermin to reverse liver fibrosis, demonstrated in metabolic dysfunction-associated steatohepatitis (a form of SLD) Unique properties offer potential for efimosfermin to be a new standard-of-care Significantly expands GSK’s hepatology pipeline aimed at addressing steatotic and viral drivers of liver disease, offering multiple development options and potential first launch in 2029 GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent progress
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom